ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
12.70
-0.18 (-1.40%)
At close: Mar 31, 2026, 4:00 PM EDT
12.61
-0.09 (-0.73%)
After-hours: Mar 31, 2026, 4:27 PM EDT
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $113.89 million as of March 31, 2026. Its market cap has increased by 353.06% in one year.
Market Cap
113.89M
Enterprise Value
107.74M
1-Year Change
353.06%
Ranking
Category
Stock Price
$12.70
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has increased from $21.82M to $113.89M, an increase of 421.91%. That is a compound annual growth rate of 12.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 115.50M | 686.25% |
| Dec 31, 2025 | 14.69M | -52.59% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agenus | 129.79M |
| Equillium | 129.61M |
| Karyopharm Therapeutics | 128.50M |
| Black Diamond Therapeutics | 122.60M |
| AN2 Therapeutics | 122.56M |
| Inovio Pharmaceuticals | 119.87M |
| Alpha Cognition | 117.62M |
| Innate Pharma | 115.51M |